Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John W Greiner

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Immunotargets and Therapy|June 3, 2021
NHS-IL12, a Tumor-Targeting ImmunocytokineJohn W Greiner, Y Maurice Morillon, Jeffrey Schlom
Mutation Research|May 13, 2005
Mouse models expressing human carcinoembryonic antigen (CEA) as a transgene: evaluation of CEA-based cancer vaccinesKenneth W Hance, Hasan E Zeytin, John W Greiner
Cancer Research|December 4, 2002
Vaccine-based therapy directed against carcinoembryonic antigen demonstrates antitumor activity on spontaneous intestinal tumors in the absence of autoimmunityJohn W Greiner, Hasan Zeytin, Miriam R Anver, et al.
Anticancer Research|September 29, 2020
The Development of Next-generation PBMC Humanized Mice for Preclinical Investigation of Cancer Immunotherapeutic AgentsY Maurice Morillon, Ariana Sabzevari, Jeffrey Schlom, et al.
Journal for Immunotherapy of Cancer|June 13, 2019
Temporal changes within the (bladder) tumor microenvironment that accompany the therapeutic effects of the immunocytokine NHS-IL12Y Maurice Morillon, Zhen Su, Jeffrey Schlom, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 28, 2012
Distinct effects of saracatinib on memory CD8+ T cell differentiationShinji Takai, Helen Sabzevari, Benedetto Farsaci, et al.
Oncotarget|April 21, 2017
Enhanced antitumor effects by combining an IL-12/anti-DNA fusion protein with avelumab, an anti-PD-L1 antibodyJonathan K Fallon, Amanda J Vandeveer, Jeffrey Schlom, et al.
Frontiers in Bioscience : a Journal and Virtual Library|June 16, 2007
Combination of physical activity, nutrition, or other metabolic factors and vaccine responseKenneth W Hance, Connie J Rogers, Stephen D Hursting, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 2, 2013
Inhibition of TGF-β1 signaling promotes central memory T cell differentiationShinji Takai, Jeffrey Schlom, Joanne Tucker, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 29, 2010
Intratumoral immunotherapy of established solid tumors with chitosan/IL-12David A Zaharoff, Kenneth W Hance, Connie J Rogers, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Immunotargets and Therapy|June 3, 2021
NHS-IL12, a Tumor-Targeting ImmunocytokineJohn W Greiner, Y Maurice Morillon, Jeffrey Schlom
Mutation Research|May 13, 2005
Mouse models expressing human carcinoembryonic antigen (CEA) as a transgene: evaluation of CEA-based cancer vaccinesKenneth W Hance, Hasan E Zeytin, John W Greiner
Cancer Research|December 4, 2002
Vaccine-based therapy directed against carcinoembryonic antigen demonstrates antitumor activity on spontaneous intestinal tumors in the absence of autoimmunityJohn W Greiner, Hasan Zeytin, Miriam R Anver, et al.
Anticancer Research|September 29, 2020
The Development of Next-generation PBMC Humanized Mice for Preclinical Investigation of Cancer Immunotherapeutic AgentsY Maurice Morillon, Ariana Sabzevari, Jeffrey Schlom, et al.
Journal for Immunotherapy of Cancer|June 13, 2019
Temporal changes within the (bladder) tumor microenvironment that accompany the therapeutic effects of the immunocytokine NHS-IL12Y Maurice Morillon, Zhen Su, Jeffrey Schlom, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 28, 2012
Distinct effects of saracatinib on memory CD8+ T cell differentiationShinji Takai, Helen Sabzevari, Benedetto Farsaci, et al.
Oncotarget|April 21, 2017
Enhanced antitumor effects by combining an IL-12/anti-DNA fusion protein with avelumab, an anti-PD-L1 antibodyJonathan K Fallon, Amanda J Vandeveer, Jeffrey Schlom, et al.
Frontiers in Bioscience : a Journal and Virtual Library|June 16, 2007
Combination of physical activity, nutrition, or other metabolic factors and vaccine responseKenneth W Hance, Connie J Rogers, Stephen D Hursting, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 2, 2013
Inhibition of TGF-β1 signaling promotes central memory T cell differentiationShinji Takai, Jeffrey Schlom, Joanne Tucker, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 29, 2010
Intratumoral immunotherapy of established solid tumors with chitosan/IL-12David A Zaharoff, Kenneth W Hance, Connie J Rogers, et al.
Pageof 4